Preliminary results of a randomized study comparing the efficacy of 2 doses of docetaxel 100 mg/m 2/3 weeks vs 75 mg/m 2/3 weeks in treatment of locally advanced or metastatic non-small cell lung cancer (NSCLC) after failure of a previous cis-platin based chemotherapy

Article de revue

Avec comité de lecture

E Quoix, B Lebeau, P Jacoulet, A Ducolonné, D Moro, B Milleron, E Lemarié, J.L Pujol, J.M Bréchot, G Zalcman, …

Lung cancer (Amsterdam, Netherlands), Vol.29(1), pp.60-60

2000

Indicateurs

1 Consultations de la notice

Titre: Preliminary results of a randomized study comparing the efficacy of 2 doses of docetaxel 100 mg/m 2/3 weeks vs 75 mg/m 2/3 weeks in treatment of locally advanced or metastatic non-small cell lung cancer (NSCLC) after failure of a previous cis-platin based chemotherapy
Créateurs - sans rôle: E Quoix - CHU Strasbourg, France
B Lebeau - HI St Antoine, France
P Jacoulet - CHU Besançon, France
A Ducolonné - HI Hautepierre, France
D Moro - Grenoble, France
B Milleron - HI Tenon, Breton, France
E Lemarié - Tours, France
J.L Pujol - Montpellier, France
J.M Bréchot - Hotel-Dieu-Paris, France
G Zalcman - Curie, France
F Vaylet - HI instruction Armées, France
D Debieuvre - Vesoul, France
A Vergnenègre - CHU Limoges, France
N Paillot - Metz, France
A.C Neidhart - CH Mulhouse, France
M Mornet - CH Bourges, France
M.P Schuller-Lebeau - Laboratoire Aventis, France
Détails de publication: Lung cancer (Amsterdam, Netherlands), Vol.29(1), pp.60-60
Éditeur: Elsevier Ireland Ltd
Nombre de pages: 1
Identifiants: 99140140209311
Unité académique: Institut de Recherche en Cancérologie de Montpellier - IRCM
Langue: English
Type de ressource: Journal article